Drug Discovery news has published an article on CDD’s work with the St. Jude Children’s Research Hospital. From the article:
A collaboration to identify and develop drugs for resistant strains of malaria draws on an unusual combination of resources: U.S. Army research from 1946 plus 21st century informatics and lab technology.
The joint work on malaria began about two years ago between Collaborative Drug Discovery Inc., (CDD) and the Department of Chemical Biology and Therapeutics at St. Jude Children’s Research Hospital. CDD created a database of over 12,000 molecules from the 61-year-old, two-volume “A Survey of Malaria Drugs,” edited by Frederick Y. Wiselogle.
Other posts you might be interested in
View All Posts
CDD Blog
19 min
June 6, 2025
Synthetic Lethality in Precision Oncology: Integrating AI-Driven Discovery with Data Management Platforms
Read More
CDD Blog
29 min
June 4, 2025
How to Choose the Right ELN or LIMS for Early-Stage Drug Discovery
Read More
CDD Blog
10 min
June 3, 2025
Chemical Registration in Drug Discovery
Read More